You are interested in buying shares of Corporación Bio-Techne (TECH), Guide

bio techne corporation

Bio-Techne Corporation, along with its subsidiaries, develops, manufactures and sells life science reagents, instruments and services for clinical diagnostic and research markets worldwide. The company operates in two segments, Protein Sciences and Diagnostics & Genomics. The Protein Sciences segment offers protein and reagent solutions, including cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and T-cell activation technologies. This segment also provides manual and automated protein analysis instruments and immunoassays for use in the quantification of proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including Food and Drug Administration regulated controls, calibrators, blood gas and clinical chemistry controls, and other reagents for OEMs and clinical customers, as well as a portfolio of clinical molecular diagnostic oncology assays comprising the ExoDx prostate test for the diagnosis of prostate cancer. This segment also manufactures and sells tissue-based in situ hybridization assays for research and clinical use. The company was previously known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota. This segment also manufactures and sells tissue-based in situ hybridization assays for research and clinical use. The company was previously known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota. This segment also manufactures and sells tissue-based in situ hybridization assays for research and clinical use. The company was previously known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota. The company was previously known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota. This segment also manufactures and sells tissue-based in situ hybridization assays for research and clinical use. The company was previously known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota. The company was previously known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota. This segment also manufactures and sells tissue-based in situ hybridization assays for research and clinical use. The company was previously known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.

You are interested in buying shares of Corporación Bio-Techne (TECH), Guide

Do you want to buy Bio-Techne Corporation (TECH) shares on Nasdaq risk-free and using an officially regulated broker? Are you interested in being able to make your savings profitable each month and get capital gains on the stock market? Here I am going to show you how you can create an account in DEGIRO , a reliable investment broker and minimum commissions, and how you will be able to obtain Bio-Techne Corporation (TECH) (TECH) shares quickly and intuitively.

The method is very simple :

  • To begin, we will register in degiro, an interface in which we will invest in shares of Corporación Bio-Techne (TECH), (TECH).
  • Then we will make a money transfer to execute our 1st investment.
  • Once we see the funds in our account, we will look for the company Bio-Techne Corporation using its ticker, that is, TECH.
  • Then we will only go on to indicate the number of shares to buy, the purchase price and the type of order.

Perhaps this tutorial has been too basic for you, so I am going to show you the purchase process with images:

Tutorial to register in Degiro

To start we are going to register in degiro through this link :

buy shares of Bio-Techne Corporation (TECH)

It will ask us for an email, a username and a password to access, and immediately we will have to continue with the link that they have sent us by email.

Immediately DeGiro is going to ask us for some essential data with the interest of ascertaining that it is us . We must have our passport number, identity document or driving document, our mobile number and the bank account number that we are going to apply to make our first deposit in IBAN format. If you do not understand what method this format is, you can review this simple tutorial that we elaborated in Educacep .

stock Bio-Techne Corporation

Once our account is admitted we will be able to pay money from the Enter / Withdraw tab. We have the possibility of proceeding to carry out a transaction that will take two to three days, or to be able to make the deposit instantly using Sofort, a 100% secure and very reliable payment gateway.

deposit money Bio-Techne Corporation

How to buy Bio-Techne Corporation (TECH) shares through DEGIRO

The moment we have the capital we will have the possibility of investing in our 1st action. You can go to the «Place order» button in the corner or use the spin finder and put the ticker. In the following image you will find that I have used the Amazon ticker but you must enter (TECH), the Bio-Techne Corporation ticker. As it is an action, we will discover that the related tickers are listed and there we will see the Bio-Techne Corporation. The most fundamental thing is that the ticker, the name of the company and the market in which it is listed coincide. Amazon is listed on NASDAQ (NDQ) and in your case Bio-Techne Corporation (TECH) is listed on Nasdaq. This step is essential so do not get confused.

American futures exchange Bio-Techne Corporation

At the time of placing the order we will look at the next . We will be able to place a limit or market order. Think you plan to buy a share of Bio-Techne Corporation at 410.24, but its price today is much more prominent. With a limit order we will place the value at which we plan to make the operation and until there are no shares selling at this value, the purchase of the share will not be executed. With a market order DeGiro will buy the number of shares we have proposed at the actual selling price, which will be very much in line with today’s trading price.

limit order with hidden volume Bio-Techne Corporation (TECH)

In one case or another it is very essential that you look at the type of alignment: fixed or of the day . As an example, in Spain, the stock market is in the morning and until 1 in the afternoon, and in the USA it corresponds to the afternoon schedule in Spain. If an order is fixed, it will continue until the point where it manages to be executed, but if you select the “of the day” option, when the trading session ends, if it has not been executed, it will be deleted from your tab in Activity – Pending Orders.

Hopefully this quick article will be useful to you to invest in Bio-Techne Corporation. Thank you very much!

  Company information
  • Bio-Techne Corporation (TECH) Address: 614 McKinley Place NE Minneapolis, MN 55413 United States 612379 8854 Website: http://www.bio-techne.com
  • Ticker: TECH
  • Sector: Sanitary
  • Industry: Biotechnology
  • Number of employees: 2,300
  • Listed market: Nasdaq
  • Value last year: $410.24

company executives

Name Title Payment exercised Year of birth
Mr. Charles R. Kummeth CEO, President and Director 2.86 million 20.79 million 1960
Mr. James T. Hippel Executive VP of Finance & FINANCE DIRECTOR 1.15 million The 4.24M 1971
Mrs. Brenda S. Furlow Sr. VP, General Counsel, Sec. & Chief Compliance Officer 821.24k 1.88 million 1958
Mr Norman David Eansor Protein Science Segment Pres 1.08 million 5.71 million 1961
Mr Kim Kelderman Pres Diagnostic and Genomics 972.4k N/A 1967
David Clair Senior Director of Investor Relations and Corp. Devel. N/A N/A N/A
Mr Gerry Andros Vice President of Sales and Marketing N/A N/A N/A
Mr. Struan Robertson Vice President of Human Resources N/A N/A N/A
Mr. Robert M. Gavin Senior Vice President of the Analytical Solutions Division N/A N/A 1968
Mr. Kevin S. Gould Senior Vice President of Diagnostic Reagents Division N/A N/A 1966

Recent Bio-Techne Corporation Events:

Recent Events May 28, 2021 Dividend Date February 11, 2021 Ex Dividend Date May 19, 2020 Completely Filed 8-K: Entering into a Definitive Material Agreement, Financial Statements and Exhibits May 11, 2020 Completely Filed 10-Q : Quarterly Report 30 Apr 2020 Full Filed 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements